Medicxi

Medicxi closes fund worth nearly $449 million, aims for investments in platforms, pipelines

While it trails its U.S. counterpart, Europe's life science sector has seen an increase in interest from investors lately. A report released Thursday by Silicon Valley Bank indicates growing investment in European biopharma and diagnostics.

By Alaric DeArment

BioPharma, Startups

Startup developing semi-synthetic protein therapies raises $63M to tame IL-2

Interleukin-2 has been plagued by low responses and scary side effects but Synthorx is adding synthetic amino acids and a polymer to the treatment in an effort to make it a more effective cancer therapy

By Josh Baxt